Graduate Students

Application Deadline: Invention to Impact Training Program Fall 2025

admin — Tue, 22 Jul 2025 20:26:48 +0000

Application Deadline: September 14, 2025, 11:59PM ET - Apply Here!

Call for Applications: Invention to Impact Training Program Fall 2025

admin — Tue, 22 Jul 2025 20:27:24 +0000

Application Deadline: September 14, 2025, 11:59PM ET - Apply Here!

Nine �鶹ɫ��Ƭians appointed to the Order of Canada

admin — Mon, 07 Jul 2025 19:10:48 +0000

Neuroscientist Alan Evans and music performance scholar Michael McMahon among �鶹ɫ��Ƭ community members recognized for exceptional accomplishments and service

Nine members of the �鶹ɫ��Ƭ community have been appointed to the Order of Canada, one of the country’s highest civilian honours.

Among the honorees are two �鶹ɫ��Ƭ faculty members, Professors Alan Evans (Faculty of Medicine and Health Sciences) and Michael McMahon (Schulich School of Music).

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

Exhibit | ouch ouch ouch

admin — Thu, 13 Mar 2025 12:49:12 +0000

La version française suit.

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

6th National Course on Sleep Medicine

admin — Thu, 12 Dec 2024 14:46:27 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

�鶹ɫ��Ƭ Healthcare-Management Case Competition (MHCC) - Date TBD

admin — Thu, 27 Mar 2025 20:14:22 +0000

GCHM and IMHL students and alumni - apply your knowledge in a real-world healthcare challenge.

�鶹ɫ��Ƭ Cares: Building your team for unplanned life transitions

admin — Tue, 15 Apr 2025 20:12:17 +0000

Join us on May 7th at noon for the next �鶹ɫ��Ƭ Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a loved one with dementia.

Save the Date: 2025 Donald G. Doehring Memorial Lecture

admin — Mon, 03 Feb 2025 18:05:51 +0000

Thursday March 27th 2025 • 4:30pm to 6pm
Leacock Building #232, 855 Sherbrooke West

Lori Leibold Ph.D.
Senior Director • Center for Hearing Research

Speaker Bio

Provost honours 31 �鶹ɫ��Ƭ professors for exceptional research achievements

admin — Thu, 01 May 2025 16:23:55 +0000

�鶹ɫ��Ƭ announces 2025 cohort of Distinguished James �鶹ɫ��Ƭ Professors, James �鶹ɫ��Ƭ Professors and William Dawson Scholars
Provost and Vice-President (Academic) Christopher Manfredi has named 31 �鶹ɫ��Ƭ professors as Distinguished James �鶹ɫ��Ƭ Professors, James �鶹ɫ��Ƭ Professors or William Dawson Scholars. The internal awards recognize exceptional research achievements.

Scaringi Lecture Series in Speech Language Pathology - Research Talk

admin — Mon, 17 Mar 2025 18:53:55 +0000

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 �鶹ɫ��Ƭ College Ave. Room 606

Sunsetting of the Vanier and Banting programs

admin — Mon, 10 Feb 2025 16:30:19 +0000

In alignment with the Tri-Agency Research Training Strategy and as announced in Budget 2024, the three federal granting agencies, the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering and Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) are working to offer a harmonized and streaml

The Child Phonology Lab at SCSD is looking for parent participants

admin — Thu, 15 May 2025 16:14:23 +0000

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

admin — Wed, 26 Mar 2025 11:03:15 +0000

Montreal, March 26, 2025 – �鶹ɫ��Ƭ’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.